MedPath

The effect of exercise and royal jelly on inflammatory factors in multiple sclerosis patients

Phase 3
Conditions
Multiple sclerosis.
Multiple sclerosis
Registration Number
IRCT20180612040073N2
Lead Sponsor
niversity of Sistan and Baluchestan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Multiple sclerosis patients: Expanded Disability Status Scale (EDSS) between 0-4
Lack of any supplement
Lack of cardiovascular disease

Exclusion Criteria

Multiple sclerosis patients: EDSS more than 4
Use of pharmaceutical supplements
With cardiovascular disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tumor necrosis factor alpha changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Tumor necrosis factor alpha test kit.;High-sensitivity C-reactive Protein Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: High-sensitivity C-reactive Protein test kit.;Neutrophils counts. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Automatic cell counting machine.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath